English

The new toolkit describes the successful 10-step process used to engage community members in the effective implementation of STD prevention and control interventions.

This video gives an overview about HIV and COVID-19.

This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.

This wepage provides information on the similarities between COVID-19 and tuberculosis, wearing a mask, reducing stigma, and more. The document is also available in English, French, Spanish, Russian, Polish, and Chinese.

This document lists competencies in the areas of knowledge, judgement, skills, and attitudes important for TB Screening.

This training manual was created to build and strengthen the capacity of people with and affected by TB to better understand the human rights issues and abuses they encounter and be able to respond constructively by building on previous experience in participating in a TB-or and human rights-related activity.

This session discusses why representation, including of persons living with hepatitis B, is essential to research, and communication and outreach strategies to improve diversity in clinical trials.

This resource highlights what's going on nationally in STDs, highlights the costs to the nation, and gives some practical tips for getting involved.

This tool provides a daily Rifampin Schedule for Latent Tuberculosis (TB) patients.

The early release tables provide National-, state-, and county-level (EHE Phase I jurisdictions only) data on the 6 core indicators  that will be used to monitor the Ending the HIV Epidemic initiative.